USPTO serial 77306027
THERAPASE
Reviewed by CopyMark Law Group
Reg. 3906108Status 710
- Filing date
- Status date
- Registration date
- Jan 18, 2011
- Examiner
- GARDNER, DAWNA BERYL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with THERAPASE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BAYER PHARMA AKTIENGESELLSCHAFT
BERLIN, DE
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
BERLIN, DE
Other trademarks owned by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
BERLIN, DE
Other trademarks owned by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Köln, DE
Köln, DE
BAYER INTELLECTUAL PROPERTY GMBH
MONHEIM AM RHEIN, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey M. Gitchel
Jeffrey M. Gitchel Bayer Corporation100 Bayer RoadPittsburgh, PA 15205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical substances for scientific and research use, namely, proteins and nucleic acids with enzyme and ribozyme properties; assays for molecular-biological research, namely, kits composed of chemical reagents for non-medical purposes | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical products based on active proteins and nucleic acids for use in treating autoimmune and inflammation diseases, diseases of the blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology diseases, respiratory and pulmonary diseases and gynecological diseases; diagnostic preparations for veterinary purposes based on active proteins and nucleic acids; medical diagnostic kits primarily composed of reagents and assays for testing amniotic fluid, blood and blood plasma, serum, semen, urine, cerebrospinal fluid and intracellular fluid, saliva, sputum, feces, lymphatic fluid, wound exudate and sanies | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and development in the field of molecular biology and providing advice on a contractual bases relating to scientific developments in molecular biology; scientific research and development of molecular-biological assays; scientific research and development of medicine and environmental analysis; scientific research and development in the fields of biological active substances and biotechnology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BAYER PHARMA AKTIENGESELLSCHAFT
- Other trademarks owned by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
- Other trademarks owned by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
- Other trademarks owned by DIREVO BioTech AG
- Other trademarks owned by DIREVO BioTech AG
- Other trademarks owned by BAYER INTELLECTUAL PROPERTY GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named THERAPASE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2017 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 10, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 18, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 25, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 24, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 18, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2010 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Oct 29, 2010 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 29, 2010 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Aug 25, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 24, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 23, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 23, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 23, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 19, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 19, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 2, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 2, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 14, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 14, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 16, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 21, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 27, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 22, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 22, 2008 | ALIE | ASSIGNED TO LIE | — |
| Dec 12, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 25, 2008 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 8, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 8, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 8, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 14, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 22, 2007 | NWAP | NEW APPLICATION ENTERED | — |